Bio-Imaging elects Olukotun to board
Bio-Imaging Technologies has chosen Adeoye Olukotun, MD, to serve as a director on the board, effective Monday.
Olukotun is co-founder and, since 2004, chief medical officer (CMO) of VIA Pharmaceuticals, a publicly traded biotechnology company based in San Francisco focused on the treatment of cardiovascular disease.
He is a board-certified cardiologist with more than twenty-five years of experience in clinical research and drug development in the pharmaceutical industry, according to the Newton, Pa.-based company. Before joining VIA, Olukotun founded CR Strategies, a clinical research and development consulting firm in Princeton, N.J., and served as its CEO from 2000 to 2003. He also was CMO of Esperion Therapeutics, a cardiovascular drug development company, until its acquisition by Pfizer in 2004.
Olukotun is co-founder and, since 2004, chief medical officer (CMO) of VIA Pharmaceuticals, a publicly traded biotechnology company based in San Francisco focused on the treatment of cardiovascular disease.
He is a board-certified cardiologist with more than twenty-five years of experience in clinical research and drug development in the pharmaceutical industry, according to the Newton, Pa.-based company. Before joining VIA, Olukotun founded CR Strategies, a clinical research and development consulting firm in Princeton, N.J., and served as its CEO from 2000 to 2003. He also was CMO of Esperion Therapeutics, a cardiovascular drug development company, until its acquisition by Pfizer in 2004.